trial

Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results

NCTId NCT04548622
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 15 (actual)
Sponsored by Yale University
Primary completion 2016-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
15 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2012-09
Primary completion
2016-10
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Magstim Rapid 2 system triggering Magstim Super Rapid system

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Philip R Corlett, PhDPrincipal Investigator

Sites

1 total
New Haven, United States

Facts & assertions

4 sourced
Enrollment
15
Phase
NA
Primary Completion Date
2016-10
Status
TERMINATED
relationships
The graph out of here
drug
Magstim Rapid 2 system triggering Magstim Super Rapid system
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Hallucinations
indication
Schizophrenia
indication
investigator
Philip R Corlett, PhD
person